-
2
-
-
23044516185
-
Migraines during pregnancy: Options for therapy
-
Fox AW, Diamond ML, Spierings EL. Migraines during pregnancy: options for therapy. CNS Drugs 2005;19(6):465-81.
-
(2005)
CNS Drugs
, vol.19
, Issue.6
, pp. 465-481
-
-
Fox, A.W.1
Diamond, M.L.2
Spierings, E.L.3
-
3
-
-
4644258730
-
Treatment of migraine headaches with sumatriptan in pregnancy
-
Epub 2004 Aug 17
-
Hilaire ML, Cross LB, Eichner SF. Treatment of migraine headaches with sumatriptan in pregnancy. Ann Pharmacother 2004;38(10):1726-30. Epub 2004 Aug 17.
-
(2004)
Ann Pharmacother
, vol.38
, Issue.10
, pp. 1726-1730
-
-
Hilaire, M.L.1
Cross, L.B.2
Eichner, S.F.3
-
4
-
-
42049097881
-
Use of 5-HT1 agonists in pregnancy
-
Epub 2008 Mar 18
-
Evans EW, Lorber KC. Use of 5-HT1 agonists in pregnancy. Ann Pharmacother 2008;42(4):543-9. Epub 2008 Mar 18.
-
(2008)
Ann Pharmacother
, vol.42
, Issue.4
, pp. 543-549
-
-
Evans, E.W.1
Lorber, K.C.2
-
5
-
-
0031763239
-
Migraine in pregnancy. What are the safest treatment options?
-
DOI 10.2165/00002018-199819050-00005
-
Pfaffenrath V, Rehm M. Migraine in pregnancy: what are the safest treatment options? Drug Saf 1998;19(5):383-8. (Pubitemid 28505196)
-
(1998)
Drug Safety
, vol.19
, Issue.5
, pp. 383-388
-
-
Pfaffenrath, V.1
Rehm, M.2
-
6
-
-
40549118490
-
Headache and pregnancy
-
Menon R, Bushnell CD. Headache and pregnancy. Neurologist 2008;14(2):108-19.
-
(2008)
Neurologist
, vol.14
, Issue.2
, pp. 108-119
-
-
Menon, R.1
Bushnell, C.D.2
-
8
-
-
38549177445
-
Acetaminophen use during pregnancy: Effects on risk for congenital abnormalities
-
DOI 10.1016/j.ajog.2007.08.040, PII S0002937807010253
-
Rebordosa C, Kogevinas M, Horváth-Puhó E, Nørgård B, Moreales M, Czeizel AE, et al. Acetaminophen use during pregnancy: effects on risk of congenital abnormalities. Am J Obstet Gynecol 2008;198(2):178.e1-7. (Pubitemid 351146603)
-
(2008)
American Journal of Obstetrics and Gynecology
, vol.198
, Issue.2
-
-
Rebordosa, C.1
Kogevinas, M.2
Horvath-Puho, E.3
Norgard, B.4
Morales, M.5
Czeizel, A.E.6
Vilstrup, H.7
Sorensen, H.T.8
Olsen, J.9
-
10
-
-
84858997587
-
-
Wilmington, NC: Kendle International Inc; Available from: Accessed 2009 Sep 29
-
GlaxoSmithKline. The sumatriptan/naratriptan/Treximet pregnancy registry. Interim report. Wilmington, NC: Kendle International Inc; 2009. Available from: http://pregnancyregistry.gsk.com/documents/sum-nar-report-spring2009-final.pdf. Accessed 2009 Sep 29.
-
(2009)
The Sumatriptan/naratriptan/Treximet Pregnancy Registry. Interim Report
-
-
-
11
-
-
23944484687
-
Exposure to rizatriptan during pregnancy: Post-marketing experience up to 30 June 2004
-
Fiore M, Shields KE, Santanello N, Goldberg MR. Exposure to rizatriptan during pregnancy: post-marketing experience up to 30 June 2004. Cephalalgia 2005;25(9):685-8.
-
(2005)
Cephalalgia
, vol.25
, Issue.9
, pp. 685-688
-
-
Fiore, M.1
Shields, K.E.2
Santanello, N.3
Goldberg, M.R.4
-
12
-
-
0035035426
-
Delivery outcome in women who used drugs for migraine during pregnancy with special reference to sumatriptan
-
Källén B, Lygner PE. Delivery outcome in women who used drugs for migraine during pregnancy with special reference to sumatriptan. Headache 2001;41(4):351-6.
-
(2001)
Headache
, vol.41
, Issue.4
, pp. 351-356
-
-
Källén, B.1
Lygner, P.E.2
-
13
-
-
0033376385
-
Pregnancy and perinatal outcomes in migraineurs using sumatriptan: A prospective study
-
O'Quinn S, Ephross SA, Williams V, Davis RL, Gutterman DL, Fox AW. Pregnancy and perinatal outcomes in migraineurs using sumatriptan: a prospective study. Arch Gynecol Obstet 1999;263(1-2):7-12.
-
(1999)
Arch Gynecol Obstet
, vol.263
, Issue.1-2
, pp. 7-12
-
-
O'Quinn, S.1
Ephross, S.A.2
Williams, V.3
Davis, R.L.4
Gutterman, D.L.5
Fox, A.W.6
-
14
-
-
0031781404
-
Pregnancy outcome following first trimester exposure to sumatriptan
-
Shuhaiber S, Pastuszak A, Schick B, Matsui D, Spivey G, Brochu J, et al. Pregnancy outcome following first trimester exposure to sumatriptan. Neurology 1998;51(2):581-3.
-
(1998)
Neurology
, vol.51
, Issue.2
, pp. 581-583
-
-
Shuhaiber, S.1
Pastuszak, A.2
Schick, B.3
Matsui, D.4
Spivey, G.5
Brochu, J.6
-
15
-
-
0036168898
-
Evidencebased assessment of pregnancy outcome after sumatriptan exposure
-
Fox AW, Chambers CD, Anderson PO, Diamond ML, Spierings EL. Evidencebased assessment of pregnancy outcome after sumatriptan exposure. Headache 2002;42(1):8-15.
-
(2002)
Headache
, vol.42
, Issue.1
, pp. 8-15
-
-
Fox, A.W.1
Chambers, C.D.2
Anderson, P.O.3
Diamond, M.L.4
Spierings, E.L.5
-
16
-
-
0037219090
-
Safety of sumatriptan in pregnancy: A review of data so far
-
Loder E. Safety of sumatriptan in pregnancy: a review of data so far. CNS Drugs 2003;17(1):1-7.
-
(2003)
CNS Drugs
, vol.17
, Issue.1
, pp. 1-7
-
-
Loder, E.1
-
17
-
-
77950523882
-
Triptan exposure during pregnancy and the risk of major congenital malformations and adverse pregnancy outcomes: Results from the Norwegian Mother and Child Cohort Study
-
Jan 28. Epub ahead of print
-
Nezvalová-Henriksen K, Spigset O, Nordeng H. Triptan exposure during pregnancy and the risk of major congenital malformations and adverse pregnancy outcomes: results from the Norwegian Mother and Child Cohort Study. Headache 2010 Jan 28. Epub ahead of print.
-
(2010)
Headache
-
-
Nezvalová-Henriksen, K.1
Spigset, O.2
Nordeng, H.3
-
18
-
-
0029924425
-
Distribution and excretion of sumatriptan in human milk
-
Wojnar-Horton RE, Hackett LP, Yapp P, Dusci LJ, Paech M, Ilett KF. Distribution and excretion of sumatriptan in human milk. Br J Clin Pharmacol 1996;41(3):217-21.
-
(1996)
Br J Clin Pharmacol
, vol.41
, Issue.3
, pp. 217-221
-
-
Wojnar-Horton, R.E.1
Hackett, L.P.2
Yapp, P.3
Dusci, L.J.4
Paech, M.5
Ilett, K.F.6
-
20
-
-
0034877516
-
Transfer of drugs and other chemicals into human milk
-
American Academy of Pediatrics Committee on Drugs.
-
American Academy of Pediatrics Committee on Drugs. Transfer of drugs and other chemicals into human milk. Pediatrics 2001;108(3):776-89.
-
(2001)
Pediatrics
, vol.108
, Issue.3
, pp. 776-789
-
-
|